Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Autores principales: Xiaoxuan Li (Autor), Xuefei Huang (Autor), Chongfei Bai (Autor), Dalian Qin (Autor), Shousong Cao (Autor), Qibing Mei (Autor), Yun Ye (Autor), Jianming Wu (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2018-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Teneligliptin is a 3rd-generation dipeptidyl peptidase-4 (DPP-4) inhibitor. There is a limited evidence regarding the effect of teneligliptin. Therefore, this study is to assess the efficacy and safety of teneligliptin in type 2 diabetes mellitus (T2DM) patients with inadequately glycemi...